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Introduction
Fibromatoses are benign fibrous tumors that arise from
the connective tissue of muscle, overlying fascia, peri-
osteum or aponeurosis.1–5 Although there is no malig-
nant or metastatic potential, fibromatoses are locally
invasive, with a high propensity for recurrence, espe-
cially when they occur in the head and neck region,
due to the proximity of vital structures.1,6 Only 12–15%
of all fibromatoses occur in the head and neck region,
26% of which originate in the submandibular area.1,6,7
Here, we present a case of fibromatosis of the subman-
dibular region and discuss the etiology, clinical pres-
entation, pathology and various treatment modalities.
Case Report
A 42-year-old woman complaining of a right subman-
dibular mass that had been growing for 2 years was
referred to our department. One year earlier, she had
undergone a biopsy of the mass at another hospital,
and the pathology report showed only fibrosis. How-
ever, the mass had continued to gradually increase in
size. Physical examination revealed a very firm, fixed,
nontender mass in the right submandibular area; there
were no other otolaryngological findings or neurolog-
ical abnormalities. T1-weighted gadolinium-enhanced
magnetic resonance imaging (MRI) revealed an en-
hanced mass measuring approximately 5.1×3.3×5.1cm
in size in the right submandibular area, with invasion
of the right mylohyoid muscle causing elevation of the
floor of the mouth (Figure 1). In addition, the right
submandibular gland was partially encased and was
displaced posteriorly. Computed tomography (CT)
showed a lobulated tumor in this area without a clear
fat plane to the surrounding tissues. Blood test results
were within normal limits.
The patient underwent wide excision of the mass
under general anesthesia. The mass, which was cystic
and solid with yellowish fluid content, was dissected
from the surrounding structures and removed com-
pletely. The surgical specimen, which weighed 86 g
and measured 9.5 × 5.0 × 4.0 cm, consisted of a single
tumorous mass plus the submandibular gland (Figure
2). Histopathological examination revealed fibromato-
sis characterized by proliferating fibroblasts with posi-
tive immunoreactivity for vimentin; it was negative for
CD34, S-100 and smooth muscle actin (Figure 3).
Collagen deposition and focal ossification were also
identified. There was no pleomorphism or mitosis in
the cells. The surgical margin was tumor-free, and the
patient had no adjuvant therapy. Her recovery was
uneventful, and there were no neurological deficits.
Follow-up at 1 year showed no recurrence, and the
patient remains under careful follow-up.
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Discussion
Fibromatoses, also called desmoid tumors, are benign
fibrous tumors that arise from the musculoaponeurotic
structures in the body.1,2 They are locally invasive, with
a propensity for recurrence after resection, but they are
not prone to metastasis nor do they have malignant
potential.1,7 Clinically, these tumors are intermediate-
grade neoplasms with biological behavior that falls
somewhere between that of benign fibromas and
well-differentiated fibrosarcomas.3,4 Owing to their
complex characteristics, they have been referred to as
desmoplastic fibromas, desmomas, aggressive fibro-
matoses and desmoid tumors.1,3 Researchers have pro-
posed several systems for categorizing fibromatoses,
the most widely accepted being that described by
Enzinger and Weiss.1,7 Their system subdivides fibro-
matoses into 2 types, superficial and deep. Superficial
fibromatoses encompass palmar, plantar, penile and
knuckle pad lesions. Deep fibromatoses include the
extra-abdominal, abdominal and intra-abdominal sub-
types. Head and neck fibromatoses belong to the
extra-abdominal subtype of deep fibromatoses.
Fibromatoses are relatively uncommon tumors,
with an estimated incidence of approximately 2–4 cases
per million patients per year.2,8 Only 12–15% of all
fibromatoses occur in the head and neck area, with
40–85% of these cases arising in the neck.1,6 The cer-
vical and supraclavicular regions are the most common
sites for head and neck fibromatoses, followed by the
face, oral cavity, scalp, paranasal sinuses, and orbital
region.1,3,9 This tumor usually manifests as a painless,
firm, slow-growing, deep-seated mass that is fixed to
the underlying soft tissues.3 It can spread through fas-
cial planes and invade surrounding structures, causing
pain, dysphagia, respiratory distress, proptosis and epis-
taxis. When airway or major vessels are involved, there
may be life-threatening consequences.3,4,6
The etiology of fibromatosis remains unclear.
Physical, endocrine and genetic factors have all been
hypothesized to play a role in the origin of fibromato-
sis; however, no compelling evidence supports any sin-
gle factor.1–5,8 Many physicians have reported patients
with a history of local trauma preceding the develop-
ment of fibromatosis, such as previous surgery or blunt
force injury. This has led to the hypothesis that imma-
ture fibroblasts engaged in healing begin uncontrolled
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Submandibular fibromatosis
Figure 1. T1-weighted gadolinium-enhanced magnetic resonance
imaging of the patient’s neck shows an enhanced mass in the
right submandibular region (arrow). The right submandibular gland
is partially encased and posteriorly displaced.
Figure 2. The surgical specimen after excision of the mass and
right submandibular gland. The incised surface is trabecular in
appearance.
Figure 3. Photomicrograph shows the interlacing bundles of fibro-
blasts (arrow) separated by variable amounts of collagen (arrow-
head) (hematoxylin & eosin, 200´).
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proliferation that leads to tumor formation. However,
there have not been enough patients with head and
neck fibromatoses after local trauma to confirm this
theory.1,3 In particular, the patient reported here had
no history of local trauma. Endocrine disturbance may
play a part in the formation of fibromatoses, because
some lesions have been found to grow during puberty
or pregnancy and then regress following menopause or
radiation-induced castration; some tumors have shown
low levels of estrogen receptors.1,3,4,9 In addition, an
inherited pattern, inappropriate gene expression and
chromosome abnormalities have been reported in some
patients with fibromatoses.1,3
Grossly, fibromatoses are firm, rubbery, grayish-
white lesions that tend to infiltrate surrounding tis-
sues so that the border of the tumor is ill-defined.1–4
Histologically, the tumors are composed of uniform,
spindle-shaped fibroblasts arranged in fascicles with
an abundant collagenous component.1–3 Mitotic fig-
ures are rare, and there are no atypical cells or hyper-
chromatic nuclei.1,3 The degree of cellularity can vary
from region to region, however, and the tumor often
invades adjacent structures.1 Owing to these clinical
and pathological characteristics, a fibromatosis may
be confused with a reactive fibrosis, myxoma, nodular
fasciitis, keloid, fibrous hamartoma, neurofibroma,
neuroma, rhabdosarcoma or fibrosarcoma.1–4,9
At present, fibromatoses are primarily treated by
complete excision with a clear margin.1,5 Several studies
have reported a correlation between a positive tumor
margin and the incidence of local recurrence.1,7,8
When the tumor occurs in the head and neck region,
the proximity of vital structures, the complexity of 
the fascial planes, and the tumor’s aggressive behavior
often make it difficult to achieve negative margins.
Thus, recurrence rates in this region are higher than
in other locations.3,7,9 Preoperative CT or MRI is es-
sential to identify tumor borders and for planning the
surgical approach to ensure extirpation of the tumor.3,6
On CT, the lesion is usually hyperattenuated and
mildly enhanced after the administration of contrast
medium. MRI will show fibromatosis as a multilobu-
lated lesion of heterogeneous signal intensity. The tu-
mor is slightly hypointense on T1-weighted imaging
and hypointense to hyperintense on T2-weighted im-
aging, with enhancement after the administration of
gadolinium.2 In patients who are not good surgical can-
didates due to medical or technical concerns, radiation
or pharmacologic therapy should be considered.
Although the efficacy of radiotherapy remains contro-
versial, there are some reports of good local control
rates using radiotherapy as either adjuvant or primary
therapy.1,5,6 Radiotherapy should thus be considered
if there is gross residual tumor or positive margins
after resection, if a tumor recurs, or if primary exci-
sion is not feasible.1,3,5 Other treatments, such as anti-
estrogen therapy, chemotherapy, steroids, nonsteroidal
anti-inflammatory drugs, ascorbic acid or castration,
have been attempted with variable success.1–3,7,9 These
alternative modalities may be tried if surgery and 
radiation fail.
In conclusion, although fibromatosis is a histolog-
ically benign neoplasm, treatment is challenging due
to its aggressive clinical behavior and propensity for
local infiltration with a tendency for recurrence. When
the tumor occurs in the head and neck region, it can
cause significant morbidity and is extremely difficult
to address. The most effective treatment is complete
excision; other therapies, including radiation and drug
treatment, may be considered if surgery is abortive or
not feasible. Due to the high incidence of recurrence,
close follow-up is essential.
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